Thermo Fisher Scientific Inc holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 134,978 | $67,165,053 | 1.16% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 8, 2025 |
| June 30, 2025 | 134,978 | $54,728,180 | 0.92% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 5, 2025 |
| Sept. 30, 2025 | 159,968 | $77,587,679 | 1.32% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 12, 2025 |
| Dec. 31, 2025 | 159,968 | $92,693,458 | 1.62% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 4, 2026 |
| March 31, 2026 | 159,828 | $78,560,257 | 1.54% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 4, 2026 |
| June 30, 2026 | 159,828 | $80,131,366 | 1.47% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 5, 2026 |
| Sept. 30, 2026 | 102,663 | $69,302,658 | 1.27% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 5, 2026 |
7 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.